AC
ABBV icon

Apex Capital’s AbbVie ABBV Stock Holding History

Apex Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-543,000
Closed -$31.4M – 53
2014
Q3 		$31.4M Buy
543,000
+66,300
+14% +$3.68M 2.23% 14
2014
Q2 		$26.9M Sell
476,700
-123,300
-21% -$6.47M 1.68% 21
2014
Q1 		$30.8M Buy
+600,000
New +$30.3M 2.17% 17

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Apex Capital's ABBV Position: Q4 2014 in Review

Apex Capital sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 543,000 shares — an estimated $31.4M sold.

Apex Capital first reported a position in ABBV in Q1 2014 and held it in 3 quarters. The position peaked at $31.4M in Q3 2014. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Apex Capital reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
  • Apex Capital sold 543,000 AbbVie shares in Q4 2014, an estimated $31.4M.
  • Apex Capital first reported a position in AbbVie in Q1 2014 and held it in 3 quarters.
  • Apex Capital's AbbVie position peaked at $31.4M in Q3 2014.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Apex Capital's 13F filing for Q4 2014, filed 5 Feb 2015.